Literature DB >> 17200705

Celiac disease: pathogenesis of a model immunogenetic disease.

Martin F Kagnoff1.   

Abstract

Celiac disease is characterized by small-intestinal mucosal injury and nutrient malabsorption in genetically susceptible individuals in response to the dietary ingestion of wheat gluten and similar proteins in barley and rye. Disease pathogenesis involves interactions among environmental, genetic, and immunological factors. Although celiac disease is predicted by screening studies to affect approximately 1% of the population of the United States and is seen both in children and in adults, 10%-15% or fewer of these individuals have been diagnosed and treated. This article focuses on the role of adaptive and innate immune mechanisms in the pathogenesis of celiac disease and how current concepts of immunopathogenesis might provide alternative approaches for treating celiac disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200705      PMCID: PMC1716218          DOI: 10.1172/JCI30253

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  95 in total

1.  Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.

Authors:  L Willemijn Vader; Dariusz T Stepniak; Evelien M Bunnik; Yvonne M C Kooy; Willeke de Haan; Jan Wouter Drijfhout; Peter A Van Veelen; Frits Koning
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

2.  HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried.

Authors:  A S Louka; S Nilsson; M Olsson; B Talseth; B A Lie; J Ek; A H Gudjónsdóttir; H Ascher; L M Sollid
Journal:  Tissue Antigens       Date:  2002-08

3.  Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.

Authors:  Luigi Maiuri; Carolina Ciacci; Ida Ricciardelli; Loredana Vacca; Valeria Raia; Salvatore Auricchio; Jean Picard; Mohamed Osman; Sonia Quaratino; Marco Londei
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

4.  Saturation of the 5q31-q33 candidate region for coeliac disease.

Authors:  S Percopo; M-C Babron; M Whalen; S De Virgiliis; I Coto; F Clerget-Darpoux; F Landolfo; L Greco
Journal:  Ann Hum Genet       Date:  2003-05       Impact factor: 1.670

5.  Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.

Authors:  Øyvind Molberg; Nina Solheim Flaete; Tore Jensen; Knut E A Lundin; Helene Arentz-Hansen; Olin D Anderson; Anne Kjersti Uhlen; Ludvig M Sollid
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

6.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Authors:  Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

7.  An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.

Authors:  G Mazzarella; M Maglio; F Paparo; G Nardone; R Stefanile; L Greco; Y van de Wal; Y Kooy; F Koning; S Auricchio; R Troncone
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

8.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease.

Authors:  Jean-Jacques Mention; Mélika Ben Ahmed; Bernadette Bègue; Ullah Barbe; Virginie Verkarre; Vahid Asnafi; Jean-Frédéric Colombel; Paul-Henri Cugnenc; Frank M Ruemmele; Elisabeth McIntyre; Nicole Brousse; Chistophe Cellier; Nadine Cerf-Bensussan
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

Review 9.  HLA in coeliac disease: unravelling the complex genetics of a complex disorder.

Authors:  A S Louka; L M Sollid
Journal:  Tissue Antigens       Date:  2003-02

10.  HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.

Authors:  Kati Karell; Andrew S Louka; Simon J Moodie; Henry Ascher; Fabienne Clot; Luigi Greco; Paul J Ciclitira; Ludvig M Sollid; Jukka Partanen
Journal:  Hum Immunol       Date:  2003-04       Impact factor: 2.850

View more
  98 in total

1.  Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease.

Authors:  Seiji Yokoyama; Kazuko Takada; Masatomo Hirasawa; Liyanage P Perera; Takachika Hiroi
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

Review 2.  Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease.

Authors:  Juanita L Merchant
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Impact of mass screening for gluten-sensitive enteropathy in working population.

Authors:  Meritxell Mariné; Fernando Fernández-Bañares; Montserrat Alsina; Carme Farré; Montserrat Cortijo; Rebeca Santaolalla; Antonio Salas; Margarita Tomàs; Elias Abugattas; Carme Loras; Ingrid Ordás; Josep-M Viver; Maria Esteve
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  Influence of breastfeeding versus formula feeding on lymphocyte subsets in infants at risk of coeliac disease: the PROFICEL study.

Authors:  Tamara Pozo-Rubio; Amalia Capilla; Jorge R Mujico; Giada de Palma; Ascensión Marcos; Yolanda Sanz; Isabel Polanco; Maria Dolores García-Novo; Gemma Castillejo; Carmen Ribes-Koninckx; Vicente Varea; Francesc Palau; Luis Ortigosa; Luis Peña-Quintana; Esther Nova
Journal:  Eur J Nutr       Date:  2012-05-11       Impact factor: 5.614

5.  Polymer chemistry: Proteins in a pill.

Authors:  Heather D Maynard
Journal:  Nat Chem       Date:  2013-07       Impact factor: 24.427

6.  Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes.

Authors:  John T Ballew; Joseph A Murray; Pekka Collin; Markku Mäki; Martin F Kagnoff; Katri Kaukinen; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

7.  Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.

Authors:  Inge L Huibregtse; Eric V Marietta; Shadi Rashtak; Frits Koning; Pieter Rottiers; Chella S David; Sander J H van Deventer; Joseph A Murray
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

8.  Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

Authors:  Lars-Egil Fallang; Elin Bergseng; Kinya Hotta; Axel Berg-Larsen; Chu-Young Kim; Ludvig M Sollid
Journal:  Nat Immunol       Date:  2009-08-30       Impact factor: 25.606

9.  Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect.

Authors:  Manuel A Silva; Jennifer Jury; Yolanda Sanz; Michelle Wiepjes; Xianxi Huang; Joseph A Murray; Chella S David; Alessio Fasano; Elena F Verdú
Journal:  Dig Dis Sci       Date:  2011-08-07       Impact factor: 3.199

10.  The unfolding story of celiac disease risk factors.

Authors:  Benjamin Lebwohl; Jonas F Ludvigsson; Peter H R Green
Journal:  Clin Gastroenterol Hepatol       Date:  2013-11-07       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.